LOGO
LOGO

Conference Calls

Sun
Mon
Tue
Wed
Thu
Fri
Sat
Company
Symbol
Event
Time
Conference Call Details
Exelixis, Inc.
Investor Conference Call
1:00 PM
Exelixis, Inc. (EXEL) and its partner Ipsen will host a Joint conference call at 1:00 PM ET on October 10, 2016, to disucss the Positive Results from Phase 2 CABOSUN Trial of Cabozantinib Versus Sunitinib. To access the live webcast, log on at www.exelixis.com To participate in the call, dial 855-299-5224 (US) or 631-267-4890 (international) and use passcode 234-026-024.